(19)
(11) EP 3 253 772 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.07.2020 Bulletin 2020/29

(45) Mention of the grant of the patent:
22.04.2020 Bulletin 2020/17

(21) Application number: 16702557.6

(22) Date of filing: 02.02.2016
(51) International Patent Classification (IPC): 
C07H 1/00(2006.01)
 C07H 17/07(2006.01)
(86) International application number:
PCT/EP2016/052165
(87) International publication number:
WO 2016/124585 (11.08.2016 Gazette 2016/32)

(54)

PROCESS FOR THE PREPARATION OF DIOSMIN

VERFAHREN ZUR HERSTELLUNG VON DIOSMIN

PROCÉDÉ DE PRÉPARATION DE DIOSMINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 03.02.2015 EP 15153537

(43) Date of publication of application:
13.12.2017 Bulletin 2017/50

(73) Proprietor: HealthTech Bio Actives, S.L.U.
08029 Barcelona (ES)

(72) Inventor:
  • LÓPEZ CREMADES, Francisco Javier
    30588 Beniel - Murcia (ES)

(74) Representative: Reitstötter Kinzebach 
Patentanwälte Sternwartstrasse 4
81679 München
81679 München (DE)


(56) References cited: : 
WO-A2-00/11009
IT-B- 1 150 612
 DE-A1- 2 740 950
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).